Mettler Toledo (MTD)
NYSEHealth CareDiagnostics & ResearchSnapshot 2026-07-08
$1248.96-3.60%
Close 2026-07-08 · 1-day change
Reading MTD? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track MTD free→NYSEHealth CareDiagnostics & ResearchSnapshot 2026-07-08
Reading MTD? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track MTD free→QuarterlyIQ Insights · MTD
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||
| Revenues | 4,089.8 | 4,026.4 | 3,872.4 | 3,788.3 | 3,919.7 | 3,717.9 | 3,085.2 | 3,008.7 | 2,379.0 | 2,341.5 | 2,309.3 | 1,968.2 |
| Total Revenues | 4,089.8 | 4,026.4 | 3,872.4 | 3,788.3 | 3,919.7 | 3,717.9 | 3,085.2 | 3,008.7 | 2,379.0 | 2,341.5 | 2,309.3 | 1,968.2 |
| Gross Profit | 2,420.6 | 2,390.6 | 2,325.6 | 2,241.3 | 2,308.0 | 2,171.6 | 1,801.0 | 1,741.2 | 1,281.9 | 1,241.1 | 1,218.3 | 1,037.2 |
| Operating Expenses & Income | ||||||||||||
| Selling, General & Admin | 1,013.8 | 998.3 | 936.3 | 904.1 | 938.5 | 944.0 | 820.2 | 819.2 | 692.7 | 684.0 | 703.6 | 588.7 |
| R&D Expenses | 204.3 | 199.4 | 189.4 | 185.3 | 177.1 | 169.8 | 140.1 | 144.0 | 116.3 | 112.5 | 116.1 | 97.0 |
| Operating Income | 1,056.6 | 1,048.9 | 1,037.2 | 973.7 | 1,070.6 | 949.4 | 748.7 | 681.4 | 402.7 | 382.6 | 349.2 | 307.5 |
| Earnings from Continuing Operations | ||||||||||||
| Interest Expense | 68.9 | 68.5 | 74.6 | 77.4 | 55.4 | 43.2 | 38.6 | 37.4 | 22.7 | 22.8 | 23.2 | 20.1 |
| EBT, Incl. Unusual Items | 1,056.6 | 1,048.9 | 1,037.2 | 973.7 | 1,070.6 | 949.4 | 748.7 | 681.4 | 402.7 | 382.6 | 349.2 | 307.5 |
| Income Tax Expense | 181.6 | 179.7 | 174.1 | 185.0 | 198.1 | 180.4 | 146.0 | 120.3 | 96.6 | 91.8 | 79.7 | 75.4 |
| Net Income | ||||||||||||
| Net Income | 875.1 | 869.2 | 863.1 | 788.8 | 872.5 | 769.0 | 602.7 | 561.1 | 306.1 | 290.8 | 269.5 | 232.1 |
| Per Share | ||||||||||||
| Basic EPS | 43.14 | 42.17 | 40.67 | 36.10 | 38.79 | 33.25 | 25.24 | 22.84 | 10.22 | 9.37 | 8.45 | 6.98 |
| Diluted EPS | 43.03 | 42.05 | 40.48 | 35.90 | 38.41 | 32.78 | 24.91 | 22.47 | 9.96 | 9.14 | 8.21 | 6.80 |
| Revenue per Share | 201.09 | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 20.3 | 20.6 | 21.2 | 21.8 | 22.5 | 23.1 | 23.9 | 24.6 | 29.9 | 31.0 | 31.9 | 33.3 |
| Diluted Weighted Avg Shares | 20.3 | 20.7 | 21.3 | 22.0 | 22.7 | 23.5 | 24.2 | 25.0 | 30.7 | 31.8 | 32.8 | 34.1 |
| Supplemental | ||||||||||||
| EBIT | 1,056.6 | 1,048.9 | 1,037.2 | 973.7 | 1,070.6 | 949.4 | 748.7 | 681.4 | 402.7 | 382.6 | 349.2 | 307.5 |
| Effective Tax Rate | 17.2% | 17.1% | 16.8% | 19.0% | 18.5% | 19.0% | 19.5% | 17.7% | 24.0% | 24.0% | 22.8% | 24.5% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.